Results from109,000-patient study show drug still reduces risk of hospitalization, death for high-risk seniors, raises questions on use in US, where it has become a go-to treatment

Coronavirus vaccine pioneer confident he will make a speedy recovery after taking his firm's virus treatment drug, says he's 'thankful' to be quadruple-vaccinated

CEO Albert Bourla says Paxlovid 'remains one of the best tools we have' to fight coronavirus, US pharma firm working to develop booster that provides immunity for a year

Chief Executive Albert Bourla says 2021 was a 'watershed year' for drugmaker, with its efforts during the pandemic 'fundamentally changed our company forever'

One healthcare provider says it believes 10 died after refusing Regeneron's treatment; medication offered at no cost to patients since September, with priority to the unvaccinated

Bourla says boosters against coronavirus will remain necessary, but anti-COVID pill 'changes everything'

In letter to Health Ministry director, Ziv Medical Center points to promising results from Amor 18's clinical trial, where all patients who received drug went on to recover

Despite being in high-risk groups, some people are turning down paxlovid, feeling their illness is too mild to be of concern, official says

Two HMOs send drugs to a handful of infected people selected because, though mildly ill with COVID-19, they are at risk of suffering serious effects

Thousands of doses of the coronavirus treatment arrive, days after Health Ministry's emergency approval of medicine